Cross protection of a Mannheimia haemolytica A1 Lkt-/Pasteurella multocida ΔhyaE bovine respiratory disease vaccine against experimental challenge with Mannheimia haemolytica A6 in calves.
Bovine respiratory disease causes significant economic losses in both beef and dairy calf industries. Although multi-factorial in nature, the disease is characterized by an acute fibrinous lobar pneumonia typically associated with the isolation of Mannheimia haemolytica. M. haemolytica A1 and A6 are the two most commonly isolated serotypes from cattle, however, the majority of vaccines have not demonstrated cross-serotype protection. In the current study, the efficacy of a novel, attenuated live vaccine, containing both M. haemolytica serotype A1 and Pasteurella multocida, was evaluated in calves challenged with M. haemolytica serotype A6. Although the challenge was more severe than expected, vaccinated calves had reduced clinical scores, lower mortality, and significantly lower lung lesion scores compared to the placebo-vaccinated control group. The results demonstrate that vaccination with an attenuated live vaccine containing M. haemolytica serotype A1 can protect calves against clinical disease following challenge with M. haemolytica serotype A6.
MSD Animal Health, Walton Manor, Walton, Milton Keynes MK7 7AJ, UK. colin.crouch@merck.com
C F
CF
Crouch
R
R
LaFleur
C
C
Ramage
D
D
Reddick
J
J
Murray
W
W
Donachie
M J
MJ
Francis
D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology*; D001483:Base Sequence; D002417:Cattle; D002418:Cattle Diseases / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D056738:Cross Protection / Q000276:immunology*; D005098:Exotoxins / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D016978:Mannheimia haemolytica / Q000145:classification / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D008969:Molecular Sequence Data; D016979:Pasteurella multocida / Q000235:genetics / Q000276:immunology*; D012766:Pasteurellosis, Pneumonic / Q000276:immunology / Q000382:microbiology / Q000401:mortality / Q000517:prevention & control*; D012703:Serotyping; D016896:Treatment Outcome; D014611:Vaccination / Q000662:veterinary; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology
D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D005098:Exotoxins; D014613:Vaccines, Attenuated; C018579:leukotoxin